Mitsui Chemicals, Inc. TSE:4183

Mitsui Chemicals : Financial Summary Results for FY2025 ＆ Outlook for FY2026

Published

Source: MarketScreener



Financial Summary

Results for FY2025 & Outlook for FY2026

Mitsui Chemicals, Inc.

＜Remarks＞

FY2025 indicates the period from April 1, 2025 to March 31, 2026.

FY2026 indicates the period from April 1, 2026 to March 31, 2027.

May 13, 2026

This summary contains forward-looking statements about the future plans, strategies, belief and performance of the Mitsui Chemicals Group as a whole and its individual consolidated companies. These forward-looking statements are not historical facts. They are expectations, estimates, forecasts and projections based on information currently available to the Mitsui Chemicals Group and are subject to a number of risks, uncertainties and assumptions, which, without limitation, include economic trends, fluctuations in foreign currency exchange rates, fluctuations in the price of raw materials, competition in markets where the Company is active, personal consumption, market demand, the tax system and other legislation. As such, actual results may differ materially from those projected and the Mitsui Chemicals Group cannot guarantee that these forward-looking statements are accurate or will be achieved.

Copyright © 2026 Mitsui Chemicals, Inc.





  1. Executive Summary

    1）Executive Summary: FY2025 Financial Results(Operating Income before Special Items) ・・ ・1 2）Executive Summary: FY2026 Financial Outlook(Operating Income before Special Items) ・・・2

  2. Results for FY2025 (April 1, 2025 - March 31, 2026)

    1. Trends of Key Market Indicators ··· 4

    2. Major Investment Projects, etc. ··· 5

    3. Consolidated Financial Highlights ··· 6-7

    4. Sales Revenue and Operating Income before Special Items by Business Segment

      (compared with FY2024 results)

    5. Operating Income before Special Items and Business Overview by Business Segment

      (compared with FY2024 results)

      ··· 8

      ··· 9-13

    6. Non-recurring Items ··· 14

    7. Consolidated Statement of Financial Position ··· 15

    8. Consolidated Statement of Cash Flows ··· 16

  3. Outlook for FY2026 (April 1, 2026 - March 31, 2027)

    1. Highlights of Consolidated Financial Outlook ··· 18-19

    2. Sales Revenue and Operating Income before Special Items of Outlook

      by Business Segment (compared with FY2025 results)

    3. Operating Income before Special Items and Business Overview by Business Segment

      (compared with FY2025 results)

      ··· 20

      ··· 21-25

    4. Shareholder Returns ··· 26

  4. Appendix ··· 28-35

Please note that this document has been translated from the original Japanese into English for the convenience of our stakeholders. The information was originally provided in Japanese. If there is any discrepancy, the Japanese language version is the official document and is available on our Japanese language website.

Copyright © 2026 Mitsui Chemicals, Inc.

Contents



1. Executive Summary

Copyright © 2026 Mitsui Chemicals, Inc.



１）Executive Summary：FY2025 Financial Results (Operating Income before Special Items)



Entire Group: Operating income before special items decreased to 100.0 billion yen in FY2025, down 1.0 billion yen from the previous year. While profit rose in the specialty chemicals domains driven primarily by volume growth, this was outweighed by negative factors in Basic & Green Materials (B&GM) including weaker demand, lower facility operating rates, and inventory valuation losses (including time-lag effects of sales price formula) reflecting lower naphtha prices.
  • Specialty chemicals domains: Operating income before special items rose to 122.1 billion yen, up 6.2 billion yen (+5%) YoY, largely due to firm sales volume in ICT Solutions, which more than offset the negative effects from decreased sales volume in Mobility Solutions associated with U.S. trade policies, semiconductor supply shortage, and an aluminum plant fire in the U.S.
  • B&GM: We recorded an operating loss before special items of 18.4 billion yen, which was down 7.0 billion yen YoY. This was due to continued low operating rates-mainly at crackers-stemming from weaker demand, as well as inventory valuation losses (including time-lag effects of sales price formula) reflecting lower naphtha prices, deteriorating market conditions, and major regular maintenance at Ichihara Works, among other factors.
  • The impact of U.S. trade policies was negative approximately 3.0 billion yen in FY2025, as Mobility Solutions saw slowdown in automotive production in North

    America, among other factors.

  • Compared with the February 5 forecast, operating income before special items was lower, primarily due to production cutbacks linked to the Middle East conflict (mainly in B&GM) and slow 4Q demand recovery in automotive applications.

  • Operating income before special items

    Volume

    Terms of trade

    (2.8)

    Specialty chemicals domains

    115.9

    +6.2

    +5%

    122.1

    124.0

(Billions of Yen)

+7.7

+1.3

Costs, etc.

()Denotes a minus

(1.0)

101.0

100.0

103.0

Total B&GM

(7.0)

FY24 FY25

FY25

(Previous Outlook on Feb 5)

(11.4)

(18.4)

(15.0)

FY24

1. Executive Summary

FY25

FY25

(Previous Outlook

on Feb 5)

FY24 FY25

１

FY25

(Previous Outlook

on Feb 5)

Copyright © 2026 Mitsui Chemicals, Inc.

２） Executive Summary ：FY2026 Financial Outlook (Operating Income before Special Items)



Entire Group: Operating income before special items is expected to be 105.0 billion yen in FY2026, an increase of 5.0 billion yen (+5%) YoY. We expect positive contributions from business growth in the specialty chemicals domains, as well as from business restructuring and the elimination of temporary factors in Basic & Green Materials (B&GM), to more than offset the negative impact of the Middle East conflict.
  • Specialty chemicals domains: Operating income before special items is expected to be 130.0 billion yen, or an increase of 7.9 billion yen (+6%) YoY. We expect firm sales in Life & Healthcare Solutions mainly in vision care and agrochemicals; growth in EBITDA in Mobility Solutions despite higher depreciation expenses resulting from capacity expansion; and sales volume expansion in ICT Solutions driven by demand growth in the cutting-edge semiconductor market.
  • B&GM: We anticipate an operating loss before special items of 3.0 billion yen, an improvement of 15.4 billion yen from the prior year. This is due to expected benefits from business restructuring and the elimination of temporary factors, as well as price increases and cost reductions.
  • The impact of the Middle East conflict: We estimate a negative impact of approximately 15.0 billion yen arising from reduced sales volume due to production cutbacks and deterioration in production yields and energy efficiency, mainly in B&GM. This impact is reflected in operating income before special items of the "Others" segment. As our Group's businesses are essential to supporting social and industrial infrastructure, we will make every effort to ensure stable product supply and will reflect rising raw material costs in selling prices in a timely manner.

  • Operating income before special items

(Billions of Yen)

Total Specialty chemicals domains

()Denotes a minus

+20.0

Mid-East conflict

+3.8

Life &

105.0

100.0

・Growth in Specialty approx.

chemicals domains (15.0)

・Recovery in B&GM

+5.0

+5%

Healthcare

±0

Mobility

+4.1

130.0

122.1

ICT

B&GM

+15.4

FY25 FY26

+7.9

+6%

FY25 FY26

FY25

(18.4)

FY26

Outlook

(3.0)

(before Mid-East conflict)

1. Executive Summary

Outlook

2 Outlook

Copyright © 2026 Mitsui Chemicals, Inc.

. Copyright © 2026 Mitsui Chemicals, Inc.